Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KHC vs GSK✓SelectedUSD · GSKKHC vs GSK performance historyLatest closeAs of+1.89%11/20
Stock and ETF performance explorer

KHC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-51.5%
GSK return
+97.4%
Excess return
-148.9%
Maximum drawdown
-76.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.9%-0.1%+2.0%+1.9%
7D+1.1%-5.3%+6.4%+3.1%
30D+8.0%-3.7%+11.7%+9.5%
3M+0.9%-7.3%+8.1%+3.5%
6M+11.6%-4.2%+15.9%+13.0%
YTD+10.1%+0.9%+9.3%+8.6%
1Y+8.6%+7.3%+1.3%+4.7%
3Y-11.2%+52.7%-63.9%-27.2%
5Y-7.5%+40.1%-47.6%-23.1%
All-51.5%+97.4%-148.9%-65.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling